Sun Pharma and Hikma enter into exclusive licensing agreement for ILUMYA for Middle East &…
ILUMYA (tildrakizumab) is an US FDA approved innovative IL-23p19 monoclonal antibody used for the treatment of adults with…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.